13F-HR filed by HARVARD MANAGEMENT CO INC
HARVARD MANAGEMENT CO INC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-10, with 46 holding rows worth $806,624,206.
- Accession
- 0000950123-23-001560
- Filer
- CIK 1082621
- Filed
- 2023-02-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 46 entries on the cover page, a total value of $806,624,206 stated on the cover page (in dollars after the unit check, H1), rows summing to $806,624,204 with VALUE read as dollars as filed, 13F file number 028-03879. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Alphabet Inc. Reg. Shares A | 02079K305 | COM | 2,411,540 | $212,770,174 | dollars as filed | |
| LIGHT & WONDER INC COM | 80874P109 | Stock | 2,678,571 | $156,964,261 | dollars as filed | |
| META PLATFORMS INC CL A | 30303M102 | COM | 1,135,916 | $136,696,131 | dollars as filed | |
| GRABHLDGSLTDFCLASSCLASSA | G4124C109 | STOK | 13,036,482 | $41,977,472 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 4,105,095 | $41,584,612 | dollars as filed | |
| PURECYCLE TECHNOLOGIES INC | 74623V111 | *W EXP 03/17/202 | 714,285 | $16,887,629 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 670,382 | $15,968,499 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 1,509,254 | $11,636,348 | dollars as filed | |
| ASMLHLDGNVFSPONSOREDADR1ADRREPS1ORDSHS | N07059210 | STOK | 20,186 | $11,029,630 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 562,379 | $10,870,786 | dollars as filed | |
| MELI KASZEK PIONEER CORP | G5S74L106 | CLASS A ORD | 1,000,000 | $9,970,000 | dollars as filed | |
| NVIDIA Corp | 67066G104 | COM | 66,368 | $9,699,020 | dollars as filed | |
| QORVO INC COM | 74736K101 | Stock | 104,669 | $9,487,198 | dollars as filed | |
| EQRX INC | 26886C107 | COM | 3,853,367 | $9,479,283 | dollars as filed | |
| Analog Devices,Inc. | 032654105 | COM | 54,568 | $8,950,789 | dollars as filed | |
| Applied Materials,Inc. | 038222105 | COM | 88,443 | $8,612,579 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 541,124 | $8,084,393 | dollars as filed | |
| LAM RESEARCH CORP | 512807108 | COM | 19,131 | $8,040,759 | dollars as filed | |
| TAIWAN SEMICONDUCTOR MFG | 874039100 | SPONSORED ADS | 107,294 | $7,992,330 | dollars as filed | |
| Advanced Micro Devices,Inc. | 007903107 | COM | 112,137 | $7,263,113 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 186,143 | $6,783,051 | dollars as filed | |
| Intel Corp | 458140100 | COM | 207,752 | $5,490,885 | dollars as filed | |
| Micron Technology,Inc. | 595112103 | COM | 107,522 | $5,373,950 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 708,385 | $5,135,791 | dollars as filed | |
| ROCKET LAB USA INC | 773122106 | COM | 1,000,000 | $3,770,000 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 289,460 | $3,618,250 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 314,762 | $3,456,087 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 498,001 | $3,037,806 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 410,714 | $2,989,998 | dollars as filed | |
| CONFLUENT INC | 20717M103 | CLASS A COM | 130,383 | $2,899,718 | dollars as filed | |
| PURECYCLE TECHNOLOGIES INC | 74623V103 | COM | 2,498,170 | $2,057,141 | dollars as filed | |
| GENERATION BIO CO | 37148K100 | COM | 510,354 | $2,005,691 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 229,144 | $1,874,398 | dollars as filed | |
| NAUTICUS ROBOTICS INC | 63911H108 | COM | 500,000 | $1,870,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 778,517 | $1,852,870 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 468,749 | $1,851,559 | dollars as filed | |
| AFFIRM HLDGS INC COM CL A | 00827B106 | Stock | 173,560 | $1,678,325 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 673,270 | $1,353,273 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 107,252 | $1,243,051 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 416,059 | $1,119,199 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 131,847 | $738,343 | dollars as filed | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 400,000 | $676,000 | dollars as filed | |
| DECIBEL THERAPEUTICS INC | 24343R106 | COM | 328,798 | $674,036 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 25,000 | $497,250 | dollars as filed | |
| Surrozen, Inc. | 86889P109 | COM | 826,852 | $481,145 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 332,610 | $131,381 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-001560 | this filing | 2023-02-10 | acceptance time not in the bulk data set |